GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (NAS:GLPG) » Definitions » Pretax Margin %

Galapagos NV (Galapagos NV) Pretax Margin % : 29.66% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Galapagos NV Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Galapagos NV's Pre-Tax Income for the three months ended in Dec. 2023 was $-67.6 Mil. Galapagos NV's Revenue for the three months ended in Dec. 2023 was $-228.1 Mil. Therefore, Galapagos NV's pretax margin for the quarter that ended in Dec. 2023 was 29.66%.

The historical rank and industry rank for Galapagos NV's Pretax Margin % or its related term are showing as below:

GLPG' s Pretax Margin % Range Over the Past 10 Years
Min: -302.38   Med: -40.06   Max: 41.88
Current: 2.35


GLPG's Pretax Margin % is ranked better than
76.63% of 1027 companies
in the Biotechnology industry
Industry Median: -176.72 vs GLPG: 2.35

Galapagos NV Pretax Margin % Historical Data

The historical data trend for Galapagos NV's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Pretax Margin % Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.79 -64.80 -50.94 -29.37 2.35

Galapagos NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.47 13.12 12.31 21.44 29.66

Competitive Comparison of Galapagos NV's Pretax Margin %

For the Biotechnology subindustry, Galapagos NV's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galapagos NV's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Pretax Margin % falls into.



Galapagos NV Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Galapagos NV's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=6.134/261.422
=2.35 %

Galapagos NV's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-67.637/-228.052
=29.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galapagos NV  (NAS:GLPG) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Galapagos NV Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV (Galapagos NV) Business Description

Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.